Compounds > capecitabine
Page last updated: 2024-08-24

capecitabine and Brain Disorders

capecitabine has been researched along with Brain Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Dirani, K; Juzych, D; Marusca, G; Wang, J1
Campana, D; Di Federico, A; Lenzi, B; Nobili, E; Nuvola, G; Sisi, M1
Armesto González, EM; Cano Calderero, FX; Cerrella Cano, C; Junquera Alonso, E; Seoane Blanco, L; Terroba Alonso, M1
Kolluri, RB; Raouf, S; Tipples, K1
Advani, PP; Fakih, MG1

Other Studies

5 other study(ies) available for capecitabine and Brain Disorders

ArticleYear
Capecitabine-induced posterior reversible encephalopathy syndrome (PRES) in a patient with gastric adenocarcinoma.
    BMJ case reports, 2023, Nov-30, Volume: 16, Issue:11

    Topics: Adenocarcinoma; Brain Diseases; Capecitabine; Female; Humans; Magnetic Resonance Imaging; Posterior Leukoencephalopathy Syndrome; Seizures; Stomach Neoplasms

2023
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
    Anti-cancer drugs, 2020, Volume: 31, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Capecitabine; Electroencephalography; Humans; Hyperammonemia; Lactulose; Lung Neoplasms; Male; Oxaliplatin; Oxaloacetates

2020
Capecitabine-induced hyperammonemic encephalopathy.
    Revista espanola de enfermedades digestivas, 2022, Volume: 114, Issue:1

    Topics: Adenocarcinoma; Aged; Ammonia; Brain Diseases; Capecitabine; Humans; Hyperammonemia; Male; Pancreatic Neoplasms

2022
Encephalopathy secondary to capecitabine chemotherapy: a case report and discussion.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2009, Volume: 15, Issue:4

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Capecitabine; Cisplatin; Deoxycytidine; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes

2009
5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabine.
    Anticancer research, 2011, Volume: 31, Issue:1

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Brain Diseases; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Hyperammonemia; Liver Neoplasms; Rectal Neoplasms; Treatment Outcome

2011